Tokyo, Japan – April 9-11, 2025 – The world-renowned CPHI Japan 2025, a premier event for the pharmaceutical raw materials and pharmaceutical industry, will be held at Tokyo Big Sight. This leading exhibition serves as a vital platform for global pharmaceutical companies, suppliers, and industry professionals to exchange ideas, discover innovations, and explore new business opportunities.
As one of the most watched companies in the pharmaceutical sector, Xiamen Origin Biotech is proud to announce its participation in CPHI Japan 2025. The company will showcase a variety of high-quality pharmaceutical raw materials, advanced formulations, and innovative solutions designed to meet the evolving needs of the global pharmaceutical market.
Xiamen Origin Biotech at CPHI Japan 2025
At this year's exhibition, Xiamen Origin Biotech will highlight its professional strength, cutting-edge technology, and commitment to quality. With a strong focus on delivering high-value-added pharmaceutical raw materials and solutions, the company continues to play a key role in supporting the sustainable growth of the pharmaceutical industry worldwide.
Why Attend CPHI Japan 2025?
Recognized as the leading pharmaceutical industry event in the Asia-Pacific region, CPHI Japan attracts thousands of international participants, including manufacturers, suppliers, and research professionals. The event provides a unique opportunity to:
- Explore the latest pharmaceutical trends and innovations
- Understand regulatory developments shaping the industry
- Build valuable partnerships with global leaders
Visit Us at Booth 6F-11
Xiamen Origin Biotech warmly welcomes all colleagues, partners, and professionals to visit Booth 6F-11. This will be a perfect opportunity for face-to-face communication, exploring new cooperation opportunities, and building stronger industry connections.